• GUEST - Donald Kotler, MD ‚ Director of GI & Immunology at St. Luke's ‚ Roosevelt Medical Center
• TOPIC - Lipodystrophy (body shape changes)
  - What we know and don't know about the causes of lipodystrophy
  - The role of the immune system in lipodystrophy and bone disorders -  Effects of HCV/HIV coinfection on lipodystrophy
  - Metabolic abnormalities (cholesterol, triglycerides, sugar, insulin resistance, diabetes)
  - Bone disorders (osteopenia, avascular necrosis)
  - Risk for heart disease
  - Ethnic differences in lipodystrophy.

• GUEST - Donald Kotler, MD ‚ Director of GI & Immunology at St. Luke's ‚ Roosevelt Medical Center
• TOPIC - Lipodystrophy (body shape changes)
  - What we know and don't know about the causes of lipodystrophy
  - The role of the immune system in lipodystrophy and bone disorders -  Effects of HCV/HIV coinfection on lipodystrophy
  - Metabolic abnormalities (cholesterol, triglycerides, sugar, insulin resistance, diabetes)
  - Bone disorders (osteopenia, avascular necrosis)
  - Risk for heart disease
  - Ethnic differences in lipodystrophy.

July 15th, 2001         ^{56K      28K} 

May 6th, 2001         ^{56K      28K} 
This is a rebroadcast of the January 7, 2001 program

• GUEST: Morris Schambelan, MD, Professor of Medicine, University of California at San Francisco - Chief of Division of Endocrinology, Director of General Research Center at San Francisco General Hospital; co-chairman of the annual Lipodystrophy Workshop
• TOPIC: Lipodystrophy and Other Adverse Effects
  Dr Schambelan's perspectives on what we know & don't know about lipodystrophy; bone problems, risk of heart disease, elevated cholesterol-triglycerides-sugar-insulin resistance-diabetes; the role of HIV medications, HIV, and the immune system in lipodystrophy.

April 29th, 2001         ^{56K      28K} 

• GUEST - Ed Acosta, PharmD., University of Alabama-Birmingham
  TOPIC - New Frontier in HIV Research--Using Therapeutic Drug Monitoring (TDM), testing drug levels in blood, to adjust drug dosing

April 22th, 2001         ^{56K      28K} 

• GUEST - Jean Anderson, Director of HIV Clinic for Women and Gynecology & Obstetrics at Johns Hopkins

• TOPIC - Women & HIV; treatment, pregnancy

April 15th, 2001         ^{56K      28K} 

• GUEST - Dr. David Burger,University Hospital Nijmegen in the Netherlands

• TOPIC - The 2nd International Workshop on Clinical Pharmacology, which took place recently in Amsterdam.
  - Therapeutic drug monitoring: testing blood drug levels to make sure patients have the right amount of drug in their blood.
  - Differences in how men and women maintain drug levels
  - and other related topics.

April 8th, 2001         ^{56K      28K} 

• GUEST - Andrew Zolopa, MD, Stanford University, Director of HIV Clinic and Researcher.

• TOPIC - Resistance Testing; Therapy Interruptions, and more

April 1st, 2001         ^{56K      28K} 

• GUEST - Donald Kotler, MD ‚ Director of GI & Immunology at St. Luke's ‚ Roosevelt Medical Center

• TOPIC - Lipodystrophy (body shape changes)
  - What we know and donผt know about the causes of lipodystrophy
  - The role of the immune system in lipodystrophy and bone disorders -  Effects of HCV/HIV coinfection on lipodystrophy
  - Metabolic abnormalities (cholesterol, triglycerides, sugar, insulin resistance, diabetes)
  - Bone disorders (osteopenia, avascular necrosis)
  - Risk for heart disease
  - Ethnic differences in lipodystrophy.

March 25th, 2001         ^{56K      28K} 

• GUEST - Michael Dube, MD ‚ Director of HIV Clinic at Indiana University

• TOPIC - Update on 8th Retrovirus Conference:
  - Lipodystrophy
  - Bone disorders (risk factors)
  - Risk for Heart Disease
  - Insulin Resistance/Diabetes
  - Elevated cholesterol, triglycerides

March 18th, 2001         This show was pre-empted by special programming

March 11th, 2001         ^{56K      28K} 

• GUESTS - Cal Cohen, MD - Harvard Vanguard Medical Group, Community Research Initiative of New England - Boston
• TOPIC - Update on 8th Retrovirus Conference:
  - Do viral load blips lead to viral load rebound?
  - Treatment interruptions
  - New drugs & salvage therapy
  - Entry Inhibitors
  - When to start therapy
  - Bone disorders in HIV
  - Triple PI regimens in salvage therapy

March 4th, 2001         ^{56K      28K} 

• GUESTS - Carl Grunfeld, MD - University of California at San Francisco, Veterans Affairs Hospital--Endocrinologist & Diabetes Specialist
• TOPIC - Current status of lipodystrophy & research--post-retrovirus update related to these topics:
  - Fat redistribution
  - bone disorders in HIV
  - how any viral syndrome causes toxicities seen in HIV, diabetes and HIV
  - sugar management in HIV
  - testing lactate levels in HIV

• GUESTS - Michelle Roland, MD - UCSF Positive Health Program
• TOPIC - Dr. Roland is directing an experimental liver transplant program for HIV/HCV co-infected patients in San Francisco. This is a national program with 10 sites in various cities. We will discuss this program and the data on transplants in co-infected people. We will talk about the challenges in implementing this program, such as reimbursement considerations.

• GUESTS - Graeme Moyle, MD - Chelsea and Westminster Hospital, London, UK
• TOPIC - 8th Conference on Retrovirus and Opportunistic Infections
              Held in Chicago from February 4th - 9th. Subjects to be discussed include:
  - New class of drugs; entry inhibitors
  STIs (structured therapy interruptions)
  - Lipodystrophy
  - Bone problems

February 11th, 2001         ^{56K      28K} 
(This is a rebroadcast of the August 20, 2000 program)

• GUESTS - Ira Jacobson, MD - Chief of GI at Cornell Hospital in NYC and Andy Talal, Head of HCV/HIV Coinfection in GI Unit at Cornell
• TOPIC - Hepatitis C (Part II)
   - Current treatments and those in development for Hepatitis: Pegylated Interferon, Herbs, diet, and alternative treatment approaches Women, African Americans, Hispanics and Hepatitis

• GUESTS - Ira Jacobson, MD - Chief of GI at Cornell Hospital in NYC and Andy Talal, Head of HCV/HIV Coinfection in GI Unit at Cornell
• TOPIC - Hepatitis C (Part I)
   - Current treatments and those in development for Hepatitis; Pegylated Interferon Herbs, diet, and alternative treatment approaches Women, African Americans, Hispanics and Hepatitis HCV and Co-infection statistics GI Clinic at Cornell Significance of HCV Genotype, HCV viral load,  cirrhosis, liver function tests

• GUEST: Jonathan Schapiro, MD, Practicing HIV Physician & Resistance Researcher at Stanford University and National Hemophilia Center, Kochar Yair, Israel
• TOPIC: Resistance Testing:
  -- The history and development of HIV resistance testing.  What is resistance? What is genotypic resistance testing? What is phenotypic resistance testing? In which situations should each type be used?
  -- How does resistance testing help you? Who performs the tests?  Can you use tests when viral load is <1000 copies/ml

January 21th, 2001         ^{56K      28K} 

• GUEST: Bernard Hirschel, MD, HUG-Hospital Cantonal, Division des Maladies Infectieuses, Geneva, Switzerland
• TOPIC: Latest Update On Structured Therapy Interruptions, STIs 

January 14th, 2001         ^{56K      28K} 

• GUEST: Doug Richman, MD, Professor of Medicine, University of California at San Diego
• TOPIC: HIV Vaccines, STI's, Resistance

January 7th, 2001         ^{56K      28K} 

• GUEST: Morris Schambelan, MD, Professor of Medicine, University of California at San Francisco - Chief of Division of Endocrinology, Director of General Research Center at San Francisco General Hospital; co-chairman of the annual Lipodystrophy Workshop
• TOPIC: Lipodystrophy and Other Adverse Effects
  Dr Schambelan's perspectives on what we know & don't know about lipodystrophy; bone problems, risk of heart disease, elevated cholesterol-triglycerides-sugar-insulin resistance-diabetes; the role of HIV medications, HIV, and the immune system in lipodystrophy.

The December 24th and 31st shows were pre-empted by special holiday programming.

December 17th, 2000         ^{56K      28K} 

• Guest: Richard M.W. Hoetelmans, PharmD, PhD - Slotervaart Hospital, Dept. of Pharmacy & Pharmacology - Amsterdam, The Netherlands
• Topics: Therapeutic Drug Monitoring (testing drug levels in blood) and pharmacology in HIV. Pros and cons of Testing drug level in blood and potential usefulness of changing doses based on drug levels.

December 10th, 2000         ^{56K      28K} 

• GUEST - David Cooper, MD -Professor of Medicine and Director, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
• TOPIC - Lipodystrophy: current state of affairs, what we know & don't know, Review of the 2nd Intl Workshop on Adverse Drug Reactions & Lipodystrophy in HIV
  - Historical perspective on HIV in Australia
  - Metabolic changes & their meaning: cholesterol, triglycerides, glucose
  - The immune system, cytokines & lipodystrophy
  - Mitochondrial toxicity & lactate levels: effect of NRTIs
  - What we know & don't know about body changes
  - Cardiac risk factors
  - Bone problems: osteopenia, avascular necrosis

December 3rd, 2000         ^{56K      28K}  

• GUEST - Mark Sulkowski, MD, John Hopkins University, Baltimore, MD

• TOPIC - We will discuss many aspects of treating coinfection & HCV:
  --When to begin therapy
  --What we know & donํt know about HIV medications & their effect on the liver when a person has HCV
  --18 months combination HCV therapy for 18 months may be better
  --Pegylated Interferon+InRibivarin๓Herbs, Vitamins, red meat & diet
  --Induction therapy
  --Incidence rate of HCV/HIV coinfection in his large urban clinic
  --HIV immune reconstitution, HIV viral load, CD4 and response to HDV therapy
  --sexual transmission of HCV: heterosexual men who have sex with men
  --Does HIV impair immune/host response to HCV?

• GUEST -  Lawrence Blatt, PhD ๑ Vice President of Research at Ribozyme Pharmaceuticals

• TOPIC - Research and Development of new therapies for HCV.
  - History of the development of interferon.
  - How interferon works.
  - New treatments for HCV:  antivirals and immune based therapies.

• GUEST - Douglas Dieterich, MD, Chief of GI and Hepatology at Cabrini Medical Center in NYC, and Clinical Associate Professor of Medicine at NYU School of Medicine
• TOPIC - Treating HIV/HCV coinfection

• GUEST - Maribel Rodriquez-Torres, MD, Gastroenterologist in San Juan Puerto Rico
• TOPIC - Treating HIV/HCV coinfection

November 5th, 2000         ^{56K      28K} 

• GUEST - Michael Norton, PA, Greenwich House; treats coinfection & HIV.
• TOPIC - HIV/HCV, coinfection & HIV treatment issues; latest data on treating coinfection from AASLD in Dallas.

October 29th, 2000         ^{56K      28K} 

• GUEST - Dr. Eugene Sun and Dr. Dale Kempf (discovered ABT-378) from Abbott Pharmaceuticals.
• TOPIC - Discussion of the new Protease Inhibitor ABT-378 (Kaletra), a new Protease Inhibitor recently approved by the FDA, which will be used to treat people with resistance to other Protease Inhibitors (salvage therapy) and people who are treatment naive (have never taken treatment).

October 22nd, 2000         ^{56K      28K} 

• GUEST - Graeme Moyle, MD - Chelsea and Westminster Hospital, London, UK
• TOPIC - 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. (Part 2 -  continuation from the previous week's discussion.)

October 15th, 2000         ^{56K      28K} 

• GUEST - Ken Lichtenstein, MD - Denver, Colorado - Treating Physician & Researcher, CDC; HIV Outpatient Study
• TOPIC - 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.

October 8th, 2000         ^{56K      28K} 

• GUEST - Don Kotler, MD - St. Luke's Hospital
• TOPIC - Lipodystrophy

 
October 1st, 2000         ^{56K      28K} 
(Rebroadcast of August 20th program)

• GUESTS - Ira Jacobson, MD - Chief of GI at Cornell Hospital in NYC and Andy Talal, Head of HCV/HIV Coinfection in GI Unit at Cornell
• TOPIC - Hepatitis C (Part II) - Current treatments and those in development for Hepatitis: Pegylated Interferon, Herbs, diet, and alternative treatment approaches Women, African Americans, Hispanics and Hepatitis

 
September 24th, 2000         ^{56K      28K} 
(Rebroadcast of July 16th program)

• GUEST - Nezam Afdhal, MD, Associate Prof. of Medicine, Harvard University School of Medicine Chief of Hepatology, Beth - Israel Deaconess Medical Center
• TOPIC - Update on Durban International AIDS Conference Strategic therapy interruptions Resistant testing, (part 2). New drugs for people with resistant viruses: ABT-378(PI), Tipranavir (PI), PMPA, T-20 (entry inhibitor), DAPD (nuke), BMS232632 (PI), Abacavir

September 17th, 2000         ^{56K      28K} 
(Rebroadcast of June 25th program)

• GUESTS - Scott Hammer, MD, Columbia-Presbyterian Medical Center in NYC
• TOPIC - Report from the 4th International Workshop on HIV Drug Resistance & Treatment Strategies in Sitges, Spain, June 12

 
September 10th, 2000         ^{56K      28K} 

• GUEST - Cal Cohen, MD ‚ Professor at The Harvard Medical School, Researcher and Treating Physician in Boston, Mass
• TOPIC - Update on Durban International AIDS Conference Strategic therapy interruptions Resistant testing, (part 2). New drugs for people with resistant viruses: ABT-378(PI), Tipranavir (PI), PMPA, T-20 (entry inhibitor), DAPD (nuke), BMS232632 (PI), Abacavir

September 3rd, 2000         ^{56K      28K} 

• GUEST - Cal Cohen, MD ‚ Professor at The Harvard Medical School, Researcher and Treating Physician in Boston, Mass
• TOPIC - Update on Durban International AIDS Conference
  (Part 2 -  continuation from the previous week's discussion.)

August 27th, 2000         ^{56K      28K} 

• GUESTS - Elinore McCance-Katz, MD ‚ Montefiore Medical Center; Director of Psychiatry and Addiction Medical Research
• TOPIC - Interactions between Methadone and HIV Medications:  Protease Inhibitors, NRTIs, and NNRTIs

August 20th, 2000         ^{56K      28K} 

• GUESTS - Ira Jacobson, MD - Chief of GI at Cornell Hospital in NYC and Andy Talal, Head of HCV/HIV Coinfection in GI Unit at Cornell
• TOPIC - Hepatitis C (Part II) - Current treatments and those in development for Hepatitis: Pegylated Interferon, Herbs, diet, and alternative treatment approaches Women, African Americans, Hispanics and Hepatitis

August 17th, 2000         ^{56K      28K} 

• GUESTS - Michael Marco, Community Advocate with Treatment Action Group, and Jeff Schouten, MD, Practicing Physician Treating HIV in Seattle, WA.
• TOPIC - Hepatitis C and HCV/HIV Co-infection.
  (This show was not able to air, but the recording of the discussion is available here.)

August 13th, 2000         ^{56K      28K} 

• GUESTS - Ira Jacobson, MD - Chief of GI at Cornell Hospital in NYC and Andy Talal, Head of HCV/HIV Coinfection in GI Unit at Cornell
• TOPIC - Hepatitis C (Part I) - Current treatments and those in development for Hepatitis; Pegylated Interferon Herbs, diet, and alternative treatment approaches Women, African Americans, Hispanics and Hepatitis HCV and Co-infection statistics GI Clinic at Cornell Significance of HCV Genotype, HCV viral load,  cirrhosis, liver function tests

August 6th, 2000         ^{56K      28K} 

• GUESTS - Don Kotler, MD ‚ St. Luke's Roosevelt Hospital
• TOPIC - Lipodystrophy Part II; What is lactic acidosis? ‚ measuring lactate levels What is midochondrial toxicity?; Possibility that lipodystrophy is  associated with the immune system disregulation; Human growth hormone treatment for fat accumulation/lipodystrophy Lipid (triglycerides/cholesterol) lowering drugs as treatments for lipodystrophy; Women and lipodystrophy

July 30th, 2000         ^{56K      28K} 

• GUESTS - Don Kotler, MD ‚ St. Luke1s Roosevelt Hospital
• TOPIC - Lipodystrophy, Part I;  Body Changes;  Metabolic Abnormalities: cholesterol, triglycerides, insulin resistance, sugar;  What is Lactic Acidosis?;  What is mitochondrial toxicity? Lipodistrophy may not be a singular syndrome. it may be a combination of up to four distinct syndromes. Research on treatments for these syndromes

July 23rd, 2000         ^{56K      28K} 

• GUESTS - Mark Wainberg, PhD, Outgoing president of The International AIDS Society; Professor of Microbiology and Medicine; McGill University, Montreal Canada .- Resistance Researcher - Dr. Wainberg and The IAS organized the Durban World AIDS Conference
• TOPIC - Why was the World Aids Conference held in Durban?  What initiatives will come out of Durban?; HIV and AIDS treatment access and stigmatization in the developing world ;  Controversy surrounding holding the Conference in Durban; South African President Mbeki and Nelson Mandela: their roles in addressing AIDS in South Africa;  Cultural issues surrounding breastfeeding in Africa.

July 16th, 2000         ^{56K      28K} 

• GUESTS - Nezam Afdhal, MD, Associate Prof. of Medicine, Harvard University School of Medicine Chief of Hepatology, Beth - Israel Deaconess Medical Center
• TOPIC - Standard of care for Hepatitis C; Goals of therapy; Pegylated interferon; Theories behind low dose maintenance therapy with interferon for individuals who did not respond virologically to interferon; HIV drugs & the liver; hi-dose induction therapy.

July 9th, 2000         ^{56K      28K}  

• GUESTS - Ray Chung, MD, Director of Liver Transplantation at Massachusetts General Hospital in Boston
• TOPIC - Standard of care for Hepatitis C; Goals of therapy; Pegylated interferon; Theories behind low dose maintenance therapy with interferon for individuals who did not respond virologically to interferon; HIV drugs & the liver; hi-dose induction therapy

July 2nd, 2000         ^{56K      28K} 

• GUESTS - Richard Haubrich, MD, University of California, San Diego, Researcher and HIV Treating Physician.
• TOPIC - Resistance Testing: The Advantages and Shortcomings of Testing

June 25th, 2000         ^{56K      28K} 

• GUESTS - Scott Hammer, MD, Columbia-Presbyterian Medical Center in NYC
• TOPIC - Report from the 4th International Workshop on HIV Drug Resistance & Treatment Strategies in Sitges, Spain, June 12-16

June 18th, 2000         ^{56K      28K} 

• GUESTS - Elaine Abrams, MD, Director of Pediatrics AIDS Program at Harlem Hospital
• TOPIC - HIV Treatment for Newborns and Older Children

June 11th, 2000         ^{56K      28K} 

• GUESTS - Steven Deeks, MD ๑ University of California, San Francisco ๑ HIV Researcher and Treating Physician
• TOPICS - STIs ๑ Update On Structured Therapy Interruptions

June 4th, 2000         ^{56K      28K} 

• GUESTS - Sai Subhasree Raghavan, PhD ๑ Columbia University Harlem Hospital ๑ Assistant Professor of Clinical Nutrition Medicine
• TOPIC - Women and Lipodistrophy; Body Changes, Osteoperosis,  Metabolic Complications (cholesterol, triglycerides, glucose); Gender and Ethnic Differences: Exercise, Diet, and Nutrition Menopause and Heart Disease; Women and HIV Treatment

May 21st, 2000         ^{56K      28K} 

• GUESTS - Andrew Zolopa, MD, Stanford University, Director of Positive Care Clinic, researcher and treating physician
• TOPIC - HIV Drug Resistance and Resistance Testing

May 15th, 2000     ^{56K      28K} 

• GUESTS - Ray Chung, MD - Medical Director of The Liver Transplant Program
  at Massachusetts General Hospital and Assistant Professor of Medicine at
  The Harvard Medical School
• TOPICS - Hepatitis C Treatment, HIV/HCV Coinfection Treatment and Policy Issues, Epidemiology Diagnosis, New models for treating coinfection, Special considerations in coinfection, Timing of biopsies

May 7th, 2000     ^{56K      28K} 

• GUESTS - Kathleen Squires, MD- University of Alabama at Birmingham; Researcher and treating physician specializing in women's issues; Member of The ACTG.
• TOPIC - HIV Treatment Issues for Women, Gender Viral Load Difference

May 1st, 2000     ^{56K      28K} 

• GUESTS - Joel Gallant, MD - Director of the Moore Clinic for treating HIV outpatients at Johns Hopkins Medical Center. Dr. Gallant also conducts a good deal of HIV research studies.
• TOPIC - Treatment issues for HIV and co-infection with Hepatitis C; When to begin therapy; What is treatment failure; When to switch therapy; Using resistance testing in selecting a new regimen Lipodystrophy & osteopenia; Importance of adherence and of seeing a doctor with extensive HIV experience; Treating the person co-infected with HIV/HCV

April 23th, 2000     ^{56K      28K} 

• GUESTS - Claire Wingfield, Gloria Searson, & Lionel Smith
• TOPIC - HCV/HIV Co-infection, treatment Issues, Treatment Education

April 9th, 2000     ^{56K      28K} 

• GUESTS - Dr. Daniel Kuritzkes, University of Colorado, Researcher and HIV Treating Physician
• TOPIC - HIV Drug Resistance Testing, Therapy Interuptions, and Other Key Current Treatment Issues

April 2nd, 2000     ^{56K      28K} 

• GUEST - David Simpson, MD, Neurologist at Mt. Sinai NYU Health System
• TOPIC - HIV & The Brain; effects on the central nervous system after HIV-infection in short-term and long-term; relationship of plasma viral load to CSF (cerebral spinal fluid) viral load; prevention, diagnosis, and treatment of HIV related nervous system dysfunction; using HAART drugs to treat dysfunction and HIV in the CSF; neuropathy; CSF reservoir and drug resistance.

March 26th, 2000     ^{56K      28K} 

• GUEST - Judith Currier, MD ๑ UCLA CARE Center
• TOPIC - Discontinuing Prophylaxis for Opportunistic Infections After Successful HAART, Womenํs Treatment Issues, Gender Differences in Viral Load

March 19th, 2000     ^{56K      28K} 

• GUEST- Steven Grinspoon, MD, Massachusetts General Hospital Neuroendocrine Unit
• TOPIC- HIV and Metabolic Complications

March 12th, 2000     ^{56K      28K} 

• GUEST ๑ Joe Eron, MD; Univeristy of North Carolina;  ACTG HIV Researcher and Treating Physician
• TOPIC -Treatment Issues: Resistance, Resistance and Reservoirs- Genital Tract, Semen, Brain, CSF, etc., New Drugs for Salvage Therapy, Resistance Testing

March 5th, 2000     ^{56K      28K} 

• GUEST - Michael Dube, MD
• TOPIC - Lipodystrophy, Fat Redistribution, Osteopenia: Highlights From Retrovirus Conference

February 27th, 2000     ^{56K      28K} 

• GUEST - Don Kotler, MD & Kees Brinkman, MD
• TOPIC - Lipodystrophy & Fat Redistribution at the 7^th Conference on Retroviruses and Opportunistic Infection

February 20th, 2000      ^{56K        28K} 

• GUEST - Cal Cohen, MD
• TOPIC - Review of 7^th Conference on Retroviruses & Opportunistic Infections
  

February 13th, 2000      ^{56K       28K} 

• GUEST - Chip Schooley, MD & Jeff Schouten, MD ๑ an HIV infected doctor
• TOPIC - Highlights from 7^th Conference on Retroviruses & Opportunistic Infection
  

February 6th, 2000        ^{56K      28K} 

• GUEST - Dr. Mark Sulkowski, Johns Hopkins University
• TOPIC - Current and Future Therapies for Hepatitis C

January 9th, 2000     ^{56K      28K} 

• GUEST - Scott Hammer, MD, Columbia-Presbyterian Hospital in NYC
• TOPIC - HIV & Hepatitis C treatment for co-infected individuals

January 2nd, 2000     ^{56K      28K} 

• GUEST - Robert Murphy, MD, Northwestern University IV
• TOPIC - Hepatitis B & C and co-infection with HIV

December 26th, 1999     ^{56K      28K} 

• GUEST - Dr. Trip Gulick, Director of the HIV Clinical Trials Units at Cornell Hospital and their satellite clinic at GMHC in New York
• TOPIC - Therapy interruptions and studies being conducted for 3 groups: acute infection, virological failures in salvage situations, and chronic disease

December 19th, 1999     ^{56K      28K} 

• GUESTS - Dr. Steven Deeks
• TOPIC - New Drugs, Salvage Therapy, PMPA & ABT-378 therapy interruptions, effectiveness of immune based therapies

December 12th, 1999     ^{56K      28K} 

• GUESTS - Dr. Graeme Moyle  - Chelsea & Westminster Hospital
• TOPIC - Lipodystrophy: When to Begin Therapy and With What Achieving long-term Viral Suppression, & Lipodystrophy Safety Studies

December 5th, 1999     ^{56K      28K} 

• GUESTS - Donna Tinnerelo, Anya Jarostchuk, Owen Wightman
• TOPIC - Discussion on Nutritional Issues and HIV

November 28th, 1999     ^{56K      28K} 

• GUESTS - Gabriel Torres, MD ๑ Bentley Salick Medical Group
• TOPIC - HIV PEP (Post Exposure Prophylaxis) Study

November 21st, 1999     ^{56K      28K} 

• GUESTS - Joep Lang, MD
• TOPIC - Various HIV Treatment Issues

November 14th, 1999     ^{56K      28K} 

• GUESTS - Dr. Mike Dube & Dr. Joep Lang
• TOPIC - Lipodystrophy

November 7th, 1999         ^{56K      28K}  

• GUESTS - Dr. Charles Farthing
• TOPIC - ICAAC Conferences on HEPC, HIV

Additional shows are being archived and uploaded weekly.